Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities

• المؤلفون الرئيسيون: Chua, Khi Pin, Teng, Yvonne HF, Tan, Aaron C, Takano, Angela, Alvarez, Jacob JS, Nahar, Rahul, Rohatgi, Neha, Lai, Gillianne GY, Aung, Zaw Win, Yeong, Joe PS, Lim, Kiat Hon, Naeini, Marjan Mojtabavi, Kassam, Irfahan, Jain, Amit, Tan, Wan Ling, Gogna, Apoorva, Too, Chow Wei, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Anantham, Devanand, Phua, Ghee Chee, Tan, Bien Soo, Lee, Yin Yeng, Wang, Lanying, Teo, Audrey SM, Khng, Alexis Jiaying, Lim, Ming Jie, Suteja, Lisda, Toh, Chee Keong, Lim, Wan-Teck, Iyer, N Gopalakrishna, Tam, Wai Leong, Tan, Eng-Huat, Zhai, Weiwei, Hillmer, Axel M, Skanderup, Anders J, Tan, Daniel SW
• مؤلفون آخرون: SURGERY
• التنسيق: مقال
• اللغة: English
• منشور في: AMER ASSOC CANCER RESEARCH 2024
• الموضوعات: Science & Technology; Life Sciences & Biomedicine; Oncology; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; OPEN-LABEL; CHECKPOINT INHIBITORS; GEFITINIB; OSIMERTINIB; EVOLUTION; AFATINIB
• الوصول للمادة أونلاين: https://scholarbank.nus.edu.sg/handle/10635/248932
• المؤسسة: National University of Singapore

10.1158/1078-0432.CCR-20-4607